The trademark application XENMYA was filed by Kite Pharma, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on August 25, 2024, and still open for oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cancer
Pharmaceutical and biological preparations for immunotherapy, including for T-Cell immunotherapy
Pharmaceutical preparations for the treatment of oncological and blood disorders.
The mark was filed in class 44 with Providing medical and healthcare information and providing medical information in the field of pharmaceuticals and cell therapy..